English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/74865
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Appraisal of a Leishmania major Strain Stably Expressing mCherry Fluorescent Protein for Both In Vitro and In Vivo Studies of Potential Drugs and Vaccine against Cutaneous Leishmaniasis

AuthorsCalvo-Álvarez, Estefanía; Guerrero, Néstor A.; Álvarez-Velilla, Raquel; Fernández Prada, Christopher; Requena, José María ; Punzón, Carmen ; Llamas, Miguel Ángel; Arévalo, Francisco J.; Rivas, Luis ; Fresno, Manuel ; Pérez-Pertejo, Yolanda; Balaña-Fouce, Rafael; Reguera, Rosa M.
KeywordsLeishmania major
Mice
Phagolysosomal compartment
Parasites
Issue Date2012
PublisherPublic Library of Science
CitationPLoS Neglected Tropical Diseases 6(11): e1927 (2012)
AbstractBackground Leishmania major cutaneous leishmaniasis is an infectious zoonotic disease. It is produced by a digenetic parasite, which resides in the phagolysosomal compartment of different mammalian macrophage populations. There is an urgent need to develop new therapies (drugs) against this neglected disease that hits developing countries. The main goal of this work is to establish an easier and cheaper tool of choice for real-time monitoring of the establishment and progression of this pathology either in BALB/c mice or in vitro assays. To validate this new technique we vaccinated mice with an attenuated Δhsp70-II strain of Leishmania to assess protection against this disease.
Methodology We engineered a transgenic L. major strain expressing the mCherry red-fluorescent protein for real-time monitoring of the parasitic load. This is achieved via measurement of fluorescence emission, allowing a weekly record of the footpads over eight weeks after the inoculation of BALB/c mice.
Results In vitro results show a linear correlation between the number of parasites and fluorescence emission over a range of four logs. The minimum number of parasites (amastigote isolated from lesion) detected by their fluorescent phenotype was 10,000. The effect of antileishmanial drugs against mCherry+L. major infecting peritoneal macrophages were evaluated by direct assay of fluorescence emission, with IC50 values of 0.12, 0.56 and 9.20 µM for amphotericin B, miltefosine and paromomycin, respectively. An experimental vaccination trial based on the protection conferred by an attenuated Δhsp70-II mutant of Leishmania was used to validate the suitability of this technique in vivo.
Conclusions A Leishmania major strain expressing mCherry red-fluorescent protein enables the monitoring of parasitic load via measurement of fluorescence emission. This approach allows a simpler, faster, non-invasive and cost-effective technique to assess the clinical progression of the infection after drug or vaccine therapy.
Publisher version (URL)http://dx.doi.org/10.1371/journal.pntd.0001927
URIhttp://hdl.handle.net/10261/74865
DOI10.1371/journal.pntd.0001927
ISSN1935-2727
Appears in Collections:(CBM) Artículos
(CIB) Artículos
Files in This Item:
File Description SizeFormat 
RequenaJM_PLosNeglTropDis_e1927.pdf735,47 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.